Skip to main content

The Carer Digital - Issue #223

Page 1

FOR NURSING AND RESIDENTIAL CARE HOMES

Happy New Year to all of our readers

W W W. T H E C A R E R U K . C O M

THECARERUK

THECARERUK

THECARER_UK

Issue 223

Groundbreaking Alzheimer’s Pill Offers New Hope for Patients in the UK

A groundbreaking new treatment for Alzheimer’s disease, developed by

the disease.

Aberdeen-based pharmaceutical company TauRX, could soon be available on

If approved by the Medicines and Healthcare products Regulatory Agency

the NHS, offering hope to millions of individuals affected by neurodegenerative

(MHRA) and the National Institute for Health and Care Excellence (NICE), HMTM

diseases. The daily oral medication, Hydromethylthionine mesylate (HMTM), is designed to slow the progression of Alzheimer’s by targeting a key protein associated with

would represent a major milestone in dementia care, marking one of the most significant advancements for NHS patients in decades.

(CONTINUED ON PAGE 3...)


Turn static files into dynamic content formats.

Create a flipbook